Interestingly, the intensity of TACE or TIMP3 mRNA tended to be associated with higher tumour stages (T-status) in this group of 57 evaluable carcinomas (P=0.067 or 0.09, respectively; Supplementary Table S1). The gene discussed is ADAM17; the disease is carcinoma.